x
Redefining the future of precision oncology through the power of
Deep Cell Science and AI — one cell at a time.
Reports arrive in pieces. Biomarkers live in silos. Decisions get harder when the evidence doesn’t connect.
We unify molecular signals into one connected intelligence layer— built so precision oncology becomes truly actionable at the point of care.
Six convictions that shape how we build, partner, and care.
Precision oncology should not be limited to a small subset of patients or institutions.
Advanced molecular science should
simplify decisions, not complicate them.
Meaningful innovation must be scalable
and relevant to real-world healthcare
systems.
Technology should support clinical judgment with deeper and more actionable insights.
Breakthroughs matter only when they improve patient outcomes.
The future of oncology depends on clinicians, scientists, and technologists working together.
"At 1Cell.Ai, we believe the smallest unit of cancer holds the biggest answers."
Our work is not just about technology. It is about the mother waiting for her results.
The oncologist searching for answers. The patient who deserves more than a statistical average.
1Cell.Ai supports clinicians and patients at every critical juncture of the cancer journey
CTC-based screening
for early detection in
asymptomatic individuals
Molecular characterisation
and staging with single-cell
precision
Drug sensitivity profiling
and resistance
identification
Real-time longitudinal
tracking of treatment
response
Recurrence surveillance
and long-term molecular
follow-up